Clinical trial · Observational
Efficacy of Cancer Support Programs: A Social Comparison Theory Analysis
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Why stopped (as posted): Terminated at time of CR - 3.26.2019 - JA
Summary
Brief summary (as posted)
The goal of this research study is to learn if a support group program is acceptable for patients with prostate cancer or patients with breast cancer. Researchers also want to learn if the characteristics of the members of the support group program can have an effect on the quality of life of other members of the support group program. Support group programs will be conducted separately for prostate cancer patients and breast cancer patients.
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Prostate Cancer | Malignant Prostate Neoplasm | CURATED_EXACT | 0.92 |
Interventions
Interventions (2)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| Group Meetings | Behavioral | — | UNRESOLVED |
| Questionnaire | Behavioral | — | UNRESOLVED |
Design
Arms and outcomes
Arms (3)
- label
- Homogeneous Support Group
- interventionNames
- Behavioral: Group Meetings
- Behavioral: Questionnaire
- label
- Heterogeneous Support Group One
- interventionNames
- Behavioral: Group Meetings
- Behavioral: Questionnaire
- label
- Heterogeneous Support Group Two
- interventionNames
- Behavioral: Group Meetings
- Behavioral: Questionnaire
Primary outcomes (1)
- measure
- Patient Psychological Functioning and Quality of Life (QOL)
- timeFrame
- Baseline and Month 3: Questionnaires & Support Group Assessments
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 21 Years
Show eligibility criteria text
Inclusion Criteria: 1. Diagnosis of prostate or breast cancer, regardless of treatment 2. No evidence of metastatic disease 3. Able to read, speak, and write English 4. Resides within one hour of M.D. Anderson Cancer Center 5. 21 years of age or older 6. Able to provide meaningful informed consent as judged by a research team member 7. Being a distressed patient: a T score greater than or equal to 63 on the Global Severity Index (GSI) of the Brief Symptom Inventory (BSI) or a T score greater than or equal to 63 on any two primary dimensions of this measure, or being a non-distressed patient: a T score of \< 63 on the GSI and a T score of \<63 on all primary dimensions of the BSI. Exclusion Criteria: 1\) None
References
Publications (0)
Data not yet available